Restricted Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Pediatric B-Lineage Acute Lymphoblastic Leukemia Suggests Targetability with Therapeutic Monoclonal AntibodiesHema Dave, Christoph Rader, Donna Butcher et al.|PLoS ONE|2012Cited by 53
Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritisRyan Malcolm Hum, Ann Brownfield, John D. Isaacs et al.|Lara D. Veeken|2022Cited by 8